This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "emphysema_protease_antiprotease_imbalance#Protease-Antiprotease Imbalance"). Key disorder-specific substitutions conforming nodes should make: cigarette-smoke COPD-emphysema enters through oxidant/particulate-driven inflammation with relatively normal alpha-1 antitrypsin levels, whereas alpha-1 antitrypsin deficiency (PiZZ/PiSZ) enters through a primary antiprotease deficit; both converge on unopposed proteolysis of the alveolar wall. Conforming nodes may substitute alveolar macrophage (CL:0000583) for the generic macrophage where the alveolar compartment is emphasized.
Oxidant and Inflammatory Trigger
trigger
Inhaled oxidants and particulates (predominantly cigarette smoke), or in the inherited route a genetic deficiency of alpha-1 antitrypsin, initiate and sustain chronic inflammation of the lower airways and alveoli. This inflammatory program recruits and activates alveolar macrophages and neutrophils, accompanied by a high level of oxidative stress that amplifies the response. This is the conserved upstream trigger from which both the acquired smoking-related and inherited deficiency routes proceed.
Downstream
-
Protease-Antiprotease Imbalance
Show evidence (2 references)
"In COPD, chronic inflammation leads to fixed narrowing of small airways and alveolar wall destruction (emphysema). This is characterized by increased numbers of alveolar macrophages, neutrophils, and cytotoxic T lymphocytes, and the release of multiple inflammatory mediators (lipids, chemokines,..."
Establishes chronic inflammation with recruitment of alveolar macrophages and neutrophils, amplified by oxidative stress, as the trigger leading to alveolar wall destruction. Evidence source is OTHER because this is a review synthesizing cellular and molecular data.
"In the lungs of CS-exposed mice, bronchial epithelial injury and bronchoalveolar lavage neutrophilia were observed. Oxidative stress and apoptosis were enhanced"
Mouse cigarette-smoke exposure recapitulates the oxidant-driven neutrophilic inflammation that initiates the emphysema cascade. Evidence source is MODEL_ORGANISM because the data derive from a murine model.
Protease-Antiprotease Imbalance
amplifier
Activated neutrophils and macrophages release excess serine proteases, chiefly neutrophil elastase, and matrix metalloproteinases. In the acquired route, oxidant inactivation of alpha-1 antitrypsin plus an increased protease burden tips the balance; in the inherited route, severe alpha-1 antitrypsin deficiency leaves elastase unopposed. Across both, the net result is excess unopposed protease activity relative to endogenous antiprotease defenses. This is the central amplifying lesion of the module.
Downstream
-
Alveolar ECM and Elastin Destruction
Show evidence (3 references)
"From the discovery that alpha-1 antitrypsin (AAT) was an effective inhibitor of neutrophil elastase originated the classic paradigm of protease/antiprotease imbalance, linking lung destruction to the unopposed effect of proteases in patients with the deficiency."
States the classic protease/antiprotease imbalance paradigm linking unopposed protease activity from alpha-1 antitrypsin deficiency to lung destruction. Evidence source is OTHER because this is a review article.
"In certain pathological circumstances, an imbalance between NE and its major plasmatic inhibitor alpha 1-PI (formerly, alpha 1-antitrypsin) leads to abnormal tissue destruction and disease development. Genetic or acquired alpha 1-PI deficiency is thought to be involved in the pathogenesis of..."
Directly describes the imbalance between neutrophil elastase and alpha-1 antitrypsin, from genetic or acquired deficiency, as the driver of tissue destruction in emphysema. Evidence source is OTHER because this is a review article.
"Inflammation, protease/anti-protease imbalance and oxidative stress play important roles in the pathogenesis of emphysema."
Confirms in a knockout-mouse study that protease/antiprotease imbalance, together with inflammation and oxidative stress, drives emphysema. Evidence source is MODEL_ORGANISM because the supporting data derive from Nrf2-knockout mice.
Alveolar ECM and Elastin Destruction
central effector
Unopposed proteolysis degrades the extracellular matrix of the alveolar wall, with the elastic fiber network surrounding the airspaces being the critical target. Elastolysis and breakdown of collagen disrupt the load-bearing matrix that stores the energy needed for normal expiration. This is the central effector step that translates the biochemical imbalance into structural matrix loss.
Downstream
-
Alveolar Wall Destruction and Airspace Enlargement
Show evidence (2 references)
"An essential feature of pulmonary emphysema is damage to the elastic fiber network surrounding the airspaces, which stores the energy needed to expel air from the lungs. The degradation of these fibers disrupts the mechanical forces involved in respiration, resulting in distension and rupture of..."
Identifies degradation of the alveolar elastic fiber/extracellular matrix network as the essential feature mediating emphysematous alveolar damage. Evidence source is OTHER because this is a review article.
"There is increased elastolysis and probable involvement of matrix metalloproteinases."
Confirms increased elastolysis and matrix metalloproteinase involvement as the proteolytic destruction of alveolar matrix. Evidence source is OTHER because this is a review article.
Alveolar Wall Destruction and Airspace Enlargement
effector
Progressive loss of the elastic and collagenous matrix leads to distension and rupture of alveolar walls, with loss of elastic recoil and a reduction in the gas-exchange surface area. Alveolar wall cells are lost through injury and apoptosis, and adjacent airspaces coalesce. The result is the structural hallmark of emphysema preceding the named clinical phenotype.
Show evidence (2 references)
"Pulmonary emphysema involves progressive destruction of alveolar walls, leading to enlarged air spaces and impaired gas exchange."
Directly describes alveolar wall destruction producing enlarged airspaces and impaired gas exchange, the effector structural change of the module. Evidence source is OTHER because this is a review article.
"This chronic exposure caused pulmonary emphysema in C57BL6/J mice accompanying prominent infiltration of macrophages and neutrophils to lung."
Demonstrates in a chronic cigarette-smoke mouse model that the inflammatory-proteolytic cascade culminates in pulmonary emphysema. Evidence source is MODEL_ORGANISM because the data derive from mice.
Emphysema
consequence
The permanent enlargement of the distal airspaces (distal to the terminal bronchioles) accompanied by destruction of their walls, without obvious fibrosis. This is the named disease-like phenotype that the protease-antiprotease and oxidant-antioxidant imbalance cascade converges upon, shared by cigarette-smoke COPD-emphysema and genetic alpha-1 antitrypsin deficiency. The clinical consequence is airflow limitation with reduced elastic recoil and impaired gas exchange.
Show evidence (2 references)
"Pulmonary emphysema involves progressive destruction of alveolar walls, leading to enlarged air spaces and impaired gas exchange."
Defines emphysema as progressive alveolar wall destruction with enlarged airspaces and impaired gas exchange, the consequence node of the module. Evidence source is OTHER because this is a review article.
"it is likely time to move on from the original protease/antiprotease hypothesis for the production of emphysema toward a more complex paradigm"
Frames emphysema as the disease produced by the protease/antiprotease paradigm (while noting additional immune mechanisms), supporting it as the terminal phenotype of this module. Evidence source is OTHER because this is a review article.